Barclays Starts Gilead Sciences (GILD) at Overweight, Sets $67 Price Target
GILD Hot Sheet
Rating Summary:12 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Barclays initiates coverage on shares of Gilead Sciences (NASDAQ: GILD) with an Overweight rating and $67 price target.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $53.73 yesterday, with a 52 week range of $34.45-$56.50.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $53.73 yesterday, with a 52 week range of $34.45-$56.50.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
- Barclays Remains Bullish on Vertex (VRTX); Upside to Phase I Data
- Wunderlich Securities Starts WW Grainger (GWW) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
